About Alvarius
Alvarius is a company based in Dublin (Ireland) founded in 2017 by James Linden. It operates as a B2B. Alvarius offers products and services including 5-MeO-DMT and Psychedelic Therapy Sessions. Alvarius operates in a competitive market with competitors including Entheon Biomedical, Clairvoyant Therapeutics and Nirvana Life Science, among others.
- Headquarter Dublin, Ireland
- Founders James Linden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Alvarius Pharmaceuticals
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alvarius
Alvarius offers a comprehensive portfolio of products and services, including 5-MeO-DMT and Psychedelic Therapy Sessions.
Treats addiction by resetting brain pathways and aiding recovery.
Combines drug administration with sessions for mental health support.
Funding Insights of Alvarius
Detailed funding history for Alvarius
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alvarius
Investment portfolio details for Alvarius
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alvarius
Detailed financials for Alvarius
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alvarius Comparisons
Peer comparison for Alvarius
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alvarius
Alvarius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Entheon Biomedical, Clairvoyant Therapeutics and Nirvana Life Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Psychedelic medicines for addiction disorders are developed and patented.
|
|
| Locked | Locked | Locked |
Psychedelic therapy drugs for addiction treatment are manufactured.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of opioid addiction
|
Detailed competitors of Alvarius
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alvarius
Complete news archive for Alvarius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alvarius
Alvarius was founded in 2017.
Alvarius is headquartered in Dublin, Ireland.
James Linden is the current CEO of Alvarius. They have also founded this company.
Alvarius is an Irish bio-pharmaceutical company focused on researching and developing therapies for addiction using 5-MeO-DMT. It combines psychedelic administration with guided psychotherapy to reset neural pathways affected by substance abuse. Collaborating with University College Dublin, the company conducts clinical trials and studies on mental health treatments. It targets patients with stimulant, opioid, and alcohol dependencies, aiming to empower recovery through innovative pharmaceutical solutions and scientific methods.
Alvarius's top competitors include Clairvoyant Therapeutics, Entheon Biomedical and Nirvana Life Science.
Alvarius offers 5-MeO-DMT and Psychedelic Therapy Sessions.